Novo Nordisk's Ozempic potentially investigated for rare eye condition (updated)
Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...
Business Insider11d
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors hoping for another blockbuster weight-loss drug. The Ozempic-maker's ...